Taiwan FDA registration a2446747b4e3f2b81657e10fcdd06eb5
EASYMAX MU Self-Monitoring Blood Glucose System
TW: 宜瑪氏專業型血糖量測系統
Taiwan·Risk Class 2·MD·EPS BIO TECHNOLOGY CORP.·Registered Oct 13, 2015 – May 02, 2028ActiveRegistration details
- Analysis ID
- a2446747b4e3f2b81657e10fcdd06eb5
- License Form
- Ministry of Health Medical Device Manufacturing No. 004957
Company information
- Manufacturer
- EPS BIO TECHNOLOGY CORP.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- EPS BIO TECHNOLOGY CORP.
Product details
- Intended Use
- This product is suitable for the Ima blood glucose test tablet, which is used to measure the glucose content in fresh microvascular whole blood samples in vitro, and is not suitable for newborn testing.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1345 Glucose Test System
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Oct 13, 2015
- Expiry Date
- May 02, 2028
About this record
Access comprehensive regulatory information for EASYMAX MU Self-Monitoring Blood Glucose System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a2446747b4e3f2b81657e10fcdd06eb5 and manufactured by EPS BIO TECHNOLOGY CORP.. The authorized representative in Taiwan is EPS BIO TECHNOLOGY CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices